- Country: Brazil
- Summary: Future and Eventual Acquisition of Medicines for Human Use (Brintellix, Buspirone Hydrochloride, Paroxetine Hydrochloride and Others), which will be Used to Comply with Court Decisions, In...
- BRT Ref No: 129723762
- Deadline: 26 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 90537/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Future and eventual acquisition of medicines for human use (brintellix, buspirone hydrochloride, paroxetine hydrochloride and others), which will be used to comply with court decisions, in compliance with the Uberlandia Municipal Health Department.
UASG Code: 926922
Notice from: 07/11/2025 from 08:00 to 17:00
Proposal Delivery: from 11/07/2025 at 08:00
VORTIOXETINE, COMPOSITION SALT BROMYDRATE, CONCENTRATION 10 MG
Quantity: 1440
CLOPIDOGREL, DOSAGE 75 MG
BUSPIRONE HYCLORHYDRATE, CONCENTRATION 10 MG
Quantity: 1440
PAROXETINE HYCLORHYDRATE, DOSAGE 20 MG
Quantity: 4320
METHYLFENIDATE HYCLORIDATE, DOSAGE 18 MG, PHARMACEUTICAL FORM CONTROLLED RELEASE
Quantity: 1440
METHYLFENIDATE HYCLORIDATE, DOSAGE 36 MG, PHARMACEUTICAL FORM CONTROLLED RELEASE
METHYLFENIDATE HYCLORIDATE, DOSAGE 54 MG, PHARMACEUTICAL FORM CONTROLLED RELEASE
Quantity: 2160
FLURAZEPAM, DOSAGE 30 MG
Quantity: 720
SODIUM DIVALPROATE, CONCENTRATION 125 MG
Quantity: 4320
TESTOSTERONE, COMPOSITION CYPIONATE SALT, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 34
DESVENLAFAXINE, COMPOSITION SUCCINATE SALT, CONCENTRATION 100 MG, PHARMACEUTICAL FORM CONTROLLED RELEASE
Quantity: 2160
FLUDROCORTISONE ACETATE, CONCENTRATION 0.1 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION, SPECIALLY MANIPULATED FORMULATION
Quantity: 1440
BIMATOPROST, COMPOSITION ASSOCIATED WITH TIMOLOL MALEATE, CONCENTRATION 0.3 MG + 5 MG/ML, PHARMACEUTICAL FORM OPHTHALMIC SOLUTION
Quantity: 40
EMPAGLIFLOZIN, CONCENTRATION 25 MG
Quantity: 2160
LEVETIRACETAM, CONCENTRATION 250 MG
Quantity: 9500
INSULIN, ASPART TYPE, COMPOSITION WITH NICOTINAMIDE (VIT B3), CONCENTRATION 100 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONS WITH APPLICATION SYSTEM
Quantity: 700
SUPPLEME... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINFuture and Eventual Acquisition of Medicines for Human Use (Brintellix, Buspirone Hydrochloride, Paroxetine Hydrochloride and Others), which will be Used to Comply with Court Decisions, In... - Brazil Tender
The GOVERNMENT OF THE STATE OF MINAS GERAIS, a Government sector organization in Brazil, has announced a new tender for Future and Eventual Acquisition of Medicines for Human Use (Brintellix, Buspirone Hydrochloride, Paroxetine Hydrochloride and Others), which will be Used to Comply with Court Decisions, In.... This tender is published on BrazilTenders under BRT Ref No: 129723762 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-26.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
